Furthermore, anti‐vWF immunohistochemistry staining revealed that AAV9‐miR‐486‐EGFP treatment improved cardiac angiogenesis in post‐MI hearts (Figure 5H; p < 0.05). This evidence concerns the gene VWF and myocardial infarction.